ARCT in the 13F filings
Arcturus Therapeutics LTD · CUSIP 03969T109
- Quarter end
- 30 Jun 2024
- the date the book describes
- Filed
- 14 Aug 2024
- latest of these filings; the earliest 26 Jul 2024
- Managers listing it
- 3
- at least, of 95 tracked, among listed positions
- Comparable managers
- 94
- filed both Q1 2024 and Q2 2024; 3 listed it in both
- Shares listed
- 3,002,407
- combined, among listed positions
- Reported value
- $73m
- combined, at the quarter end
Among the 94 comparable managers: 1 buyer (opened or added shares) and 3 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +45,933.
Managers listing ARCT in Q2 2024
3 of 3 holders
| Action | Filing | |||||
|---|---|---|---|---|---|---|
| ARK Investment Management LLC | 1,964,964 | $48m | 0.42% | Added | +275,315 | 26 Jul 2024 (the filing on sec.gov) |
| Woodline Partners LP | 754,023 | $18m | 0.18% | Trimmed | -160,341 | 14 Aug 2024 (the filing on sec.gov) |
| Schonfeld Strategic Advisors LLC | 283,420 | $6.9m | under 0.1% | Trimmed | -63,074 | 14 Aug 2024 (the filing on sec.gov) |
Largest increases and reductions, by shares
Increases
- ARK Investment Management LLCexisting position · 1,964,964 shares now+275,315
Reductions
- Woodline Partners LPexisting position · 754,023 shares now-160,341
- Schonfeld Strategic Advisors LLCexisting position · 283,420 shares now-63,074
New positions and exits
New (0)
No new position among listed positions.
Exited (1)
- Caxton Associates LLPwas $202k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2019 | 1 | $9.5m | n.a. | n.a. |
| Q3 2019 | 1 | $13m | n.a. | n.a. |
| Q4 2019 | 1 | $15m | n.a. | n.a. |
| Q1 2020 | 1 | $21m | n.a. | n.a. |
| Q2 2020 | 3 | $107m | n.a. | n.a. |
| Q3 2020 | 5 | $129m | n.a. | n.a. |
| Q4 2020 | 1 | $172m | n.a. | n.a. |
| Q1 2021 | 3 | $150m | n.a. | n.a. |
| Q2 2021 | 1 | $98m | n.a. | n.a. |
| Q3 2021 | 3 | $128m | n.a. | n.a. |
| Q4 2021 | 2 | $93m | n.a. | n.a. |
| Q1 2022 | 3 | $77m | n.a. | n.a. |
| Q2 2022 | 3 | $61m | n.a. | n.a. |
| Q3 2022 | 2 | $45m | n.a. | n.a. |
| Q4 2022 | 2 | $47m | n.a. | n.a. |
| Q1 2023 | 2 | $67m | n.a. | n.a. |
| Q2 2023 | 2 | $85m | n.a. | n.a. |
| Q3 2023 | 3 | $76m | n.a. | n.a. |
| Q4 2023 | 4 | $111m | 2 | 1 |
| Q1 2024 | 4 | $100m | 1 | 3 |
| Q2 2024 | 3 | $73m | 1 | 3 |
| Q3 2024 | 4 | $77m | 4 | 0 |
| Q4 2024 | 4 | $62m | 3 | 1 |
| Q1 2025 | 3 | $38m | 1 | 2 |
| Q2 2025 | 3 | $43m | 0 | 2 |
| Q3 2025 | 2 | $47m | 1 | 1 |
| Q4 2025 | 1 | $16m | 13 | 12 |
| Q1 2026 | 1 | $21m | 12 | 8 |
| Q2 2026 | 1 | $19m | 13 | 8 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
ARCT and LLY →ARCT and JNJ →ARCT and VRTX →Choose a stock to compare with ARCT →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own ARCT, latest filings →Back to the 13F Explorer →